Form 4 for BNGO Bionano Genomics, Inc.
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-17 · accession 0001821605-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | 2026-02-17 | BNGO | Chaubey Alka | Chief MEDICAL Off | F - Tax | $1.10 | -18 | 644 | -3% | -$19.80 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-17 | F | D | 18 | $1.10 | 644 | D | — | — |